Open Biology (Jan 2014)

USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling

  • Lina Herhaus,
  • Mazin A. Al-Salihi,
  • Kevin S. Dingwell,
  • Timothy D. Cummins,
  • Lize Wasmus,
  • Janis Vogt,
  • Richard Ewan,
  • David Bruce,
  • Thomas Macartney,
  • Simone Weidlich,
  • James C. Smith,
  • Gopal P. Sapkota

DOI
https://doi.org/10.1098/rsob.140065
Journal volume & issue
Vol. 4, no. 5

Abstract

Read online

Protein kinase ALK3/BMPR1A mediates bone morphogenetic protein (BMP) signalling through phosphorylation and activation of SMADs 1/5/8. SMAD6, a transcriptional target of BMP, negatively regulates the BMP pathway by recruiting E3 ubiquitin ligases and targeting ALK3 for ubiquitin-mediated degradation. Here, we identify a deubiquitylating enzyme USP15 as an interactor of SMAD6 and ALK3. We show that USP15 enhances BMP-induced phosphorylation of SMAD1 by interacting with and deubiquitylating ALK3. RNAi-mediated depletion of USP15 increases ALK3 K48-linked polyubiquitylation, and reduces both BMP-induced SMAD1 phosphorylation and transcription of BMP target genes. We also show that loss of USP15 expression from mouse myoblast cells inhibits BMP-induced osteoblast differentiation. Furthermore, USP15 modulates BMP-induced phosphorylation of SMAD1 and transcription during Xenopus embryogenesis.

Keywords